Trough:peak ratio of nifedipine gastrointestinal therapeutic system and nifedipine retard in essential hypertensive patients: An Italian multicentre study

Journal of Hypertension

Volumn 14, Issue 5, 1996, Pages 661-667

  Salvetti, Antonio ^a   Virdis, Agostino ^a   Taddei, Stefano ^a   Ambrosoli, Sergio ^a   Caiazza, Alberto ^b   Gandolfi, Ennio ^c   Del Prato, Carlo ^c   Saba, Giancarlo ^d   Nello Ceccarelli, Carlo ^d   Buoninconti, Raffaello ^e   Spadari, Giovanni ^f   Kilama, Michael Ochan ^f  

^a UNIVERSITY OF PISA   (Italy)

^b Civic Hospital of Fidenza   (Italy)

^c Civic Hospital of La Spezia   (Italy)

^d Asl 1 Toscana   (Italy)

^e Policlinico Universitario   (Italy)

^f Medical Department   (Italy)

Author keywords

Antihypertensive treatment; Essential hypertension; Nifedipine; Trough:peak ratio

Indexed keywords

NIFEDIPINE;

ADULT; AGED; ARTICLE; ASTHENIA; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; EDEMA; ESSENTIAL HYPERTENSION; FEMALE; HEADACHE; HEART PALPITATION; HOT FLUSH; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPHYGMOMANOMETER; SYSTOLIC BLOOD PRESSURE;

EID: 0029898598     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199605000-00017     Document Type: Article

References (19)

1. Rose M, McMahon FG: Some problems with antihypertensive drug studies in the context of the new guidelines. Am J Hypertens 1990, 3:151-155.
2. Food and Drug Administration: Proposed Guidelines for the Clinical Evaluation of Antihypertensive Drugs. Rockville, Maryland: Division of Cardio-Renal Drug Products, USA Department of Health and Human Services; 1988.
3. Salvetti A, Di Venanzio L: Clinical pharmacology of long-acting calcium antagonists: what relevance for therapeutic effects? J Cardiovasc Pharmacol 1994, 23 (suppl 5):S31-S34.
4. Myers MG: Dihydropyridine calcium antagonists and the trough:peak ratio: focus on adverse effects. J Hypertens 1994, 12 (suppl 8):S73-S77.
5. Zanchetti A, on behatf of the Italian Nifedipine GITS Study Group: Trough:peak ratio of the blood pressure response to dihydropyridine calcium antagonists. J Hypertens 1994, 12 (suppl 8):S97-S106.
6. Mancia G: Ambulatory blood pressure monitoring: research and clinical applications. J Hypertens 1990, 8 (suppl 7):S1-S13.
7. Trazzi S, Mutti E, Frattola A, Imholz B, Parati G, Mancia G: Reproducibility of non-invasive and intra-arterial blood pressure monitoring: implications for studies on antihypertensive treatment. J Hypertens 1991, 9:115-119.
8. Mancia G, Omboni S, Parati G, Trazzi S, Mutti E: Limited reproducibility of hourly blood pressure values obtained by ambulatory blood pressure monitoring: implications for studies on antihypertensive drugs. J Hypertens 1992, 10:1531-1535.
9. Zanchetti A, for the Italian Nifedipine GITS Study Group, Bianchi L, Bozza M, Omboni S, Villani A, Ravogli A: Antihypertensive effect of nifedipine GITS on clinic and ambulatory blood pressure in essential hypertensives. High Blood Press 1994, 3:45-56.
10. Stornello M, Pedrinelli R, Valvo E, Scapellato L, Salvetti A: Humoral and haemodynamic interactions between clonidine and nifedipine in human essential hypertension. J Hypertens 1985, 3 (suppl 3):S227-S229.
11. Salvetti A, Innocenti PF, Iardella M, Pambianco F, Saba GC, Rossetti M, et al.: Captopril and nifedipine interactions in the treatment of essential hypertensives: a crossover study. J Hypertens 1987, 5 (suppl 4):S139-S142.
12. General discussion on methodological aspects of the trough:peak measurement. J Hypertens 1994, 12 (suppl 8):S27-S28.
13. Salvetti A, Cardellino G, Pesenti M, Caiazza A, Ghisoni F, del Prato C, et al.: Antihypertensive effect of slow-release nicardipine. A placebo-controlled cross-over study. Eur J Clin Pharmacol 1989, 36:439-442.
14. Meredith PA, Elliott HL: Amiodipine: clinical relevance of a unique pharmacokinetic profile. J Cardiovasc Pharmacol 1993, 22 (suppl A):S6-S8.
15. Arzilli F, Gandolfi E, del Prato C, Innocenti P, Ponzanelli F, Caiazza A, et al.: Antihypertensive effect of once daily sustained release isradipine: a placebo controlled cross-over study. Eur J Clin Pharmacol 1993, 44:23-25.
16. McMahon FG, Reder RF: The relationship of dose to the antihypertensive response of verapamil-sustained release in patients with mild to moderate essential hypertension. J Clin Pharmacol 1989, 29:1003-1007.
17. Mutti E, Trazzi S, Omboni S, Parati G, Mancia G: Effect of placebo on 24-h non-invasive ambulatory blood pressure. J Hypertens 1991, 9:361-364.
18. Banzet O, Colin JN, Thibonnier M, Singlas E, Alexandre JM, Corvol P: Acute antihypertensive effect and pharmacokinetics of a tablet preparation of nifedipine. Eur J Clin Pharmacol 1983, 24:145-150.
19. Chung M, Reitberg DP, Gaffney M, Singleton W: Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system. Am J Med 1987, 83 (suppl 6B):10-14.